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piiq Angioten.i.llTYP.l ReceptOrEXpre-iO. i.th.
Myocardium Immediately Following
lschemia-Reperfusion
B. Yang, P.Ambuehl, Ml. Phillips, J.L. Mehta. Urriversifyof F/orida and the
VAMedical Center Gainesville, FL, USA
Myocardial ischemia ia known to upragulate renin-angiotensin system in
peripheral tissues, which may determine eventual outcome by affecting sys-
temic hemodynamica. To examine if angiotenain II receptor expression in the
myooardium is altered irrmradiatelyfollowing iaohemia-repeffusion, isolated
buffer perfused Sprague-Dawley rat hearts were subjected to continuous
perfuaion (control, n =5) or to 25 min of global ischemia followed by 30 min
of reperfusion (n = 5). Autoradiography of multiple myocardial sections was
performed and angiotensin II (type 1 and type 2) receptor expression quan-
titated. While continuous perfusion of hearts resulted in minor changes (~
5-10%) in coronary perfusion pressure (CPP), left ventricular end-diastolic
pressure (LVEDP) and developed left ventricular preasure (dLVP = LVSP
—LVEDP), ischemia-reperfusion caused marked increase in CPP (55 + 2
to 102 + 8 mmHg, P < 0.01) and LVEDP (5 + 1 to 55 + 6 mmHg, P <
0.01), and daoreaae in dLVP (52 * e to 19.2=9 mmHg, P < 0.01), indi-
cating marked csrdiac dysfunction. Total myocardial angiotensin II receptor
expression was greater in hearta subjected to ischemia-repaffusion than in
the continuously perfused hearts (39.1 & 7.8 vs. 23.7 + 0.5 fmol/g, P <
0.05). Moat of the increase in angiotensin II receptor expression was due to
increase in type 1 receptor (ATi) receptor expression (27.4 + 8.2 vs. 21.0 +
4.8 fmol/g, P < 0.05), asAT2 raoeptorexpression was unaffected (12.1 + 5.2
ve 12.6 + 3.2, P-NS). To examine the role of ATI expression, some hearts
were perfused with angiotensin II ATI receptor antagonist Iosartan (l O-s
M). Perfuaion of hearts with Iosartan significantly attenuated the ischemia-
reperfusion-induoed cardiac dysfunction and abolished the increase in AT1
expression. Thus, there ia increased myocardial ATI expression immediately
after ischemisdrepeffuaion,and this may contribute to cardiac dysfunction in
thia setting.
a90135 Nitric Oxide Openethe Second Window ofCardioprotection of iachemic Preconditioning:
Roie of induction of Heat Shock Protein (HSP72)
W.-J. l-i, M. Kitakaze, T. Minamino, K. Node, M. Hori. The First Depatimerrt
of Medicine, Oaaka University School of Medicine, Suita, Japan
HSP72 plays an important role in the second window of cardioprotection
(SWOP) of ischemic premnditioning (1P).Since nitric oxide (NO) is repcmad
to bainvolvad inheat-inducad expressionof HSP72inthe heart, reexamined
whether NO mediates IP-inducad expression of HSP72, and thus opening
of the SWOP. Rabbits were subjected to 4 times of 5-rein corona~ artery
occlusion separated by 10-min reperfusion (IP,n= 12)orwere sham operated
(Sham, n = 12). During IP or aham-operation, animals received intravenous
bolus injection of either 10 m~kg of NQ-nitro-L-arginine methyl ester (L-
NAME, an inhibitor of NOsynthase) 5 min before IPfollowad by a continuous
infusion of 1.5 mgfkg/min of L-NAME (IP + L-NAME, n = 12;Sham + L-NAME,
n = 12) or equal volume of aaline. Twenty-four houra after 1Por the sham-
operation, heaft rate and blood pressure were not different among 4 groups.
Immunoblotting of HSP72 revealed that 1P increased HSP72 content 24
houraafter, which was inhibited by L-NAME. In the IP rabbita, infarct size (IS)
normalized by risk area was reduced mmpared with Sham (27.4 + 3.9 vs.
53.1 + 5.3%, p -=0.01), which waa also blunted by L-NAME (52.2 + 5.7%).
There was no difference in IS between Sham and Sham + L-NAME (48.7
A 3.3%). These findings indicate that inhibition of NO synthesis during 1P
abolishea the SWOP of IP associated with the inhibition of HSP72 induction.
NO may open the second window of ischemic preconditioning via induction
of HSP72.
a90136 ischemic preconditioning both iimits infarct size
and decreases internucieosomai DNA
fragmentation in rat heart in vivo
C.A. Piot, D. Padmanaban, R.E. Sievere, C.L. Wolfe. Division of Cardiology
Univeraityof California, San Francisco, CA, USA
Previous studies have demonstrated that iachemic preconditioning limits
infarct size (i.e., pravents myocyte cell death) in rat heari in vivo. Although
both apoptosis (programmed cell death) and necrosis have been shown to
contribute independently to myocardial cell death after myocardial ischemia
and repetiusion in vivo, the ability of ischemic preconditioning to prevent
programmed call death remains unknown. Toevaluatethe potential protective
effect of iachemic preconditioning on infarct size and programmed cell death,
rata that underwent iachemic preconditioning (n = 15) and controls (n = 15)
were subjactedto 30minutes of Ieftcoronafy arlef’yocdusion followed by 180
minutes of reperfusion. Ischemic preconditioning was accomplished by five 5-
minute cycles of iachemia, each followed by 5 minutes of reperfusion. Infarct
size, determined by dual staining with TTC and phthalocyanine blue dye, was
significantly reduced in preconditioned rats compared to controls (14.2 +
3.6% vs. 59.7 + 1.8%; n =6 in each group; p c 0.001; infarct sizahiskaraa).
Semi quantificative determination of intemuclaosomal DNA fragmentation
was performed by analyzing the pattern of low m.w. DNA (180 bp multiples)
after electrophoresis on 1.5% agarose gel. DNA from preconditioned hearts
(n =9) showed little or no intemucleoaomal cleavage, whereas DNA from
control hearts (n= 9) showad typical nuclaosome fragmentation. Conclusion:
these data show that ischemic preconditioning may reduce infarct aize in ret
heart in vivo in part by preventing programmed cell death after prolonged
ischemia and reperfusion.
1901-37]The Mechani5m0fLid0cainS-indL2cedMY0cardiai
infarct Reduction Requires Locai Deiivety Prior to
Reperfusion
R. Lee, T. Nina, R.B. Schuessler, W.A. Gay, Jr. Washington University
School of Medicine, St. Louis, MO, USA
Intravenous Iidocaine limits the extent of myocardial reperfusion injury when
administered prior to, but not 80 minutes after, coronary artery occlusion.
We hypothesized that delivery of Iidocaine into the coronary sinus before
reperfusion would decrease infarct size in a clinically relevant model of
coronaty artery occlusion and reperfusion. In 24 porcine hearta, the left
anterior descending artery (LAD) was occluded with a snare distal to ita
second diagonal branch for a total of 90 min. After one hour of occlusion, the






*The doae was a 2 m@kg bolua over 30 min followed by peripheral infusionof 0.04
mgikglminfor the durationof the experiment.
After 90 min of ischemia, the snare was released, and the myccardium
was reparfusadforthraa houra.Theanimala were then euthanized. The LAD
was m-occluded, and the area at risk and infarct size were defined by Evana
blue and TTC staining. Using planimetry, the infarct as a percentage of the
area at fisk was determined.
Results:
Group 1 2 3 4
Area at RiafdAreaof LV (%) 26.1 + 7.6 23.9* 4.2 22.0& 7.6 28.1 *3.4
Area of fnfarcf/Areaat Risk (“A) 76.7+ 7.1 73.5 & 6,2 72.1 l 6.7 54.5& 10”
*SignificantlydifferentfromGroups 1, 2 and 3 by ANOVA (ps 0.008)
Conclusion.’Lidocaine reduction of infarct size requires 100aldelivery prior
to reparfusion. This suggests that the primary mechanism of Iidooaine in my-
ocardial protection from reperfusion injury targets the vascular endothelium






interventions for Stabie versus Unatebie Angina
S. Yazdani, L.1.Kovar, AD. Simon, W. Wang, C. Gulotta, A. Schwartz,
LE. Rabbani. Columbia- Presbyterian Medical Centec New York, NY USA,
St. Francis Hospital, Roslyn, NY USA
Recentstudies have demonstrated elevated systemic levels of various hemo-
static factors in unatableangina which may correlate with instability of athero-
matous plaqueaas well as severity of the clinical syndrome. We examined the
levels of tissue plasminogen activator (TPA), von Wiliebrand Factor (vWF)
and plasminogen activator inhibitor-1 (PAI-1) in patients with stable angina
(SA) and unstable angina (UA) undergoing angioplasty or atent placement.
Fifty-nine patients (42 with SA, 17 with UA) were enrolled. Patients with
infectious, malignant or inflammatory conditions were excluded. Blocd aafn-
ples were drawn immediately befora the procedure and again at one month
follow-up. Plasma levels of hemostatic factors were measured by ELK%%.
